Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss ...

All three can be given in one visit, usually at no cost under federal rules and private-insurance coverage. If you’re unsure ...

"We were both barely functional. I even wondered if we were having simultaneous heart failure," Debra DeAngelo told Newsweek.

(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...

A case series describes 41 US children with influenza-related acute necrotizing encephalopathy (ANE) that killed 27% of ...

Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ETCompany ParticipantsBrian Foard - Executive VP & Head of ...